Abstract:This study investigates the role of miR‐185 in osteoclast differentiation and migration. We demonstrated that miR‐185 depletion promoted the osteoclast differentiation in bone marrow‐derived monocytes/macrophages. Overexpression of miR‐185‐5p in RAW264.7 cells inhibited osteoclast differentiation and migration. Furthermore, we identify Btk as a target gene of miR‐185‐5p. Btk modulation may influence osteoclastic differentiation and migration through the RANK and ITAM signaling pathways. Background Bones undergo a constant remodeling, a process involving osteoclast‐mediated bone resorption and osteoblast‐mediated bone formation, crucial for maintaining healthy bone mass. We previously observed that miR‐185 depletion may promote bone formation by regulating Bgn expression and the BMP/Smad signaling pathway. However, the effects of miR‐185‐5p on the osteoclasts and bone remodeling have not been elucidated, warranting further exploration. Methods Tartrate‐resistant acid phosphatase staining was utilized to assess the differentiation ability of bone marrow mononuclear macrophages (BMMs) from mmu‐miR‐185 gene knockout (KO) mice and wild‐type (WT) mice. A reverse transcriptase‐quantitative PCR was conducted to compare differences in miR‐185‐5p and osteoclast marker molecules, including Trap, Dcstamp, Ctsk and Nfatc1, between the KO group and WT group BMMs. Western blot analysis was employed to observe the expression of osteoclast marker molecules. A cell‐counting kit‐8 was used to analyze cell proliferation ability. Transwell experiments were conducted to detect cell migration. Dual‐luciferase reporter assays were employed to confirm whether Btk is a downstream target gene of miR‐185‐5p. Results miR‐185 depletion promoted osteoclast differentiation in bone marrow‐derived monocytes/macrophages. Overexpression of miR‐185‐5p in RAW264.7 cells inhibited differentiation and migration of osteoclasts. Furthermore, Btk was identified as a downstream target gene of miR‐185‐5p, suggesting that miR‐185‐5p may inhibit osteoclast differentiation and migration by targeting Btk. Conclusions miR‐185 regulates osteoclasts differentiation, with overexpression of miR‐185‐5p inhibiting osteoclast differentiation and migration in vitro. Additionally, miR‐185‐5p may modulate osteoclastic differentiation and migration by regulating Btk expression.

Unique cartilage matrix-associated protein inhibits osteoclast differentiation by alleviating RANKL-induced reactive oxygen species

Mineralizing Solution and Dexamethasone Enhance Receptor Activator for NF-κB Ligand Expression in Rat Bone Marrow Stromal Cells

Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a

Low-intensity Pulsed Ultrasound Inhibits RANKL-induced Osteoclast Formation Via Modulating ERK-c-Fos-NFATc1 Signaling Cascades.

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway

Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms

Inhibition of JNK and Activation of the AMPK-Nrf2 Axis by Corosolic Acid Suppress Osteolysis and Oxidative Stress

Microbial chaperonin 60 inhibits osteoclast differentiation by interfering with RANK/RANKL binding and overexpression of lipocalin2

CRISPR/Cas9 knockout of MTA1 enhanced RANKL-induced osteoclastogenesis in RAW264.7 cells partly via increasing ROS activities

Angelica Sinensis Extract Inhibits RANKL-mediated Osteoclastogenesis by Down-Regulated the Expression of NFATc1 in Mouse Bone Marrow Cells

mmu‐miR‐185 regulates osteoclasts differentiation and migration by targeting Btk

CDDO-Me, Sulforaphane and Tbhq Attenuate the RANKL-induced Osteoclast Differentiation Via Activating the NRF2-mediated Antioxidant Response.

The role of calcium release activated calcium channels in osteoclast differentiation

Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival

Suppression of bone resorption by Mori Radicis Cortex through NFATc1 and c-Fos signaling-mediated inhibition of osteoclast differentiation

Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2

Cerium Oxide Nanoparticles Regulate Osteoclast Differentiation Bidirectionally by Modulating the Cellular Production of Reactive Oxygen Species

Dominant negative MCP-1 blocks human osteoclast differentiation

Inhibitory Effect of (2R)-4-(4-hydroxyphenyl)-2-butanol 2-O-β-d-apiofuranosyl-(1→6)-β-d-glucopyranoside on RANKL-Induced Osteoclast Differentiation and ROS Generation in Macrophages

Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation